SG11201809177UA - Composition for use in the prophylaxis of allergic disease - Google Patents
Composition for use in the prophylaxis of allergic diseaseInfo
- Publication number
- SG11201809177UA SG11201809177UA SG11201809177UA SG11201809177UA SG11201809177UA SG 11201809177U A SG11201809177U A SG 11201809177UA SG 11201809177U A SG11201809177U A SG 11201809177UA SG 11201809177U A SG11201809177U A SG 11201809177UA SG 11201809177U A SG11201809177U A SG 11201809177UA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- rule
- dgla
- applicant
- prophylaxis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16172431 | 2016-06-01 | ||
| PCT/EP2017/055680 WO2017207124A1 (fr) | 2016-06-01 | 2017-03-10 | Composition destinée à être utilisée dans la prophylaxie de maladies allergiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201809177UA true SG11201809177UA (en) | 2018-12-28 |
Family
ID=56108531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201809177UA SG11201809177UA (en) | 2016-06-01 | 2017-03-10 | Composition for use in the prophylaxis of allergic disease |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP3463332B1 (fr) |
| CN (1) | CN109152759A (fr) |
| AR (1) | AR107869A1 (fr) |
| BR (1) | BR112018073060A2 (fr) |
| CA (1) | CA3024191C (fr) |
| ES (1) | ES2877810T3 (fr) |
| MX (1) | MX2018014140A (fr) |
| PH (1) | PH12018502252A1 (fr) |
| PT (1) | PT3463332T (fr) |
| SG (1) | SG11201809177UA (fr) |
| TW (1) | TWI803459B (fr) |
| WO (1) | WO2017207124A1 (fr) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5591446A (en) * | 1989-04-04 | 1997-01-07 | Beiersdorf, A.G. | Methods and agents for the prophylaxis of atopy |
| GB9217780D0 (en) * | 1992-08-21 | 1992-10-07 | Efamol Holdings | Fatty acid treatment |
| GB9217781D0 (en) * | 1992-08-21 | 1992-10-07 | Efamol Holdings | Fatty acid treatment |
| CA2119000A1 (fr) * | 1993-03-19 | 1994-09-20 | David Frederick Horrobin | Formulation pour fumeurs |
| EP0711503A3 (fr) * | 1994-11-14 | 1997-11-26 | Scotia Holdings Plc | Lait fortifié avec GLA et/ou DGLA |
| GB9510636D0 (en) * | 1995-05-25 | 1995-07-19 | Scotia Holdings Plc | Fatty acid treatment |
| US20040076695A1 (en) * | 2002-07-08 | 2004-04-22 | Advanced Vision Research | EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
| JP5546087B2 (ja) * | 2005-02-14 | 2014-07-09 | サントリーホールディングス株式会社 | 皮膚疾患経口治療または予防剤 |
-
2017
- 2017-03-10 EP EP17711109.3A patent/EP3463332B1/fr active Active
- 2017-03-10 PT PT177111093T patent/PT3463332T/pt unknown
- 2017-03-10 CA CA3024191A patent/CA3024191C/fr active Active
- 2017-03-10 MX MX2018014140A patent/MX2018014140A/es unknown
- 2017-03-10 WO PCT/EP2017/055680 patent/WO2017207124A1/fr unknown
- 2017-03-10 SG SG11201809177UA patent/SG11201809177UA/en unknown
- 2017-03-10 ES ES17711109T patent/ES2877810T3/es active Active
- 2017-03-10 BR BR112018073060-2A patent/BR112018073060A2/pt not_active Application Discontinuation
- 2017-03-10 CN CN201780031490.3A patent/CN109152759A/zh active Pending
- 2017-03-13 AR ARP170100624A patent/AR107869A1/es unknown
- 2017-03-13 TW TW106108163A patent/TWI803459B/zh active
-
2018
- 2018-10-22 PH PH12018502252A patent/PH12018502252A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3024191C (fr) | 2024-05-28 |
| EP3463332A1 (fr) | 2019-04-10 |
| AR107869A1 (es) | 2018-06-13 |
| EP3463332B1 (fr) | 2021-04-21 |
| MX2018014140A (es) | 2019-02-25 |
| PT3463332T (pt) | 2021-06-30 |
| CN109152759A (zh) | 2019-01-04 |
| BR112018073060A2 (pt) | 2019-04-09 |
| TW201742624A (zh) | 2017-12-16 |
| TWI803459B (zh) | 2023-06-01 |
| ES2877810T3 (es) | 2021-11-17 |
| WO2017207124A1 (fr) | 2017-12-07 |
| PH12018502252A1 (en) | 2019-08-19 |
| CA3024191A1 (fr) | 2017-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201909963YA (en) | Methods for treating dravet syndrome | |
| SG11201809344QA (en) | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde | |
| SG11201909960UA (en) | Methods for improving memory and cognition and for treating memory and cognitive disorders | |
| SG11201407580YA (en) | Composition comprising two antibodies engineered to have reduced and increased effector function | |
| SG11201907032RA (en) | Amino pyrimidine compounds useful as ssao inhibitors | |
| SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| SG11201407837WA (en) | Beta-hairpin peptidomimetics | |
| SG11201810371XA (en) | ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF | |
| SG11201901558VA (en) | Pth compounds with low peak-to-trough ratios | |
| SG11201807597UA (en) | Methods of treating depression using orexin-2 receptor antagonists | |
| SG11201907356SA (en) | Piperidine-substituted mnk inhibitors and methods related thereto | |
| SG11201805001UA (en) | Method of treating influenza a | |
| SG11201806544XA (en) | Compounds and methods of treating rna-mediated diseases | |
| SG11201402986RA (en) | Kinase inhibitors | |
| SG11201807255YA (en) | Treatment of autoimmune diseases with combinations of rxr agonists and thyroid hormones | |
| SG11201805755SA (en) | Methods of administering hepcidin | |
| SG11201901673SA (en) | Imidazole derivatives and their use in the treatment of autoimmune or inflammatory diseases or cancers | |
| SG11201810618QA (en) | Depot formulations | |
| SG11201804587QA (en) | Isoindole compounds | |
| SG11201806424TA (en) | Therapeutic compounds | |
| SG11201408171SA (en) | Fbxo3 inhibitors | |
| SG11201908065YA (en) | Deuterated imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| SG11201806127XA (en) | Pharmaceutical or nutritional combination comprising beta-hydroxy-betamethylbutyrate | |
| SG11201810801QA (en) | Brain delivery protein | |
| SG11201901689YA (en) | Compounds for treating diseases associated with a mitochondrial dysfonction |